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ABSTRACT: Magainin and PGLa are 23- and 21-residue peptides isolated from the skin of the African clawed

frog Xenopus lueuis. They protect the frog from infection and exhibit a broad-spectrum antimicrobial activity
in vitro. T h e mechanism of this activity involves the interaction of magainin with microbial membranes.
We have measured the secondary structure and membrane-perturbing ability of these peptides to obtain
information about this mechanism. Our results show that mgn2a forms a helix with an average length of
less than 20 A upon binding to liposomes. A t high concentrations (50 mg/mL) mgn2a spontaneously
solubilizes phosphatidylcholine liposomes a t temperatures above the gel-liquid-crystalline phase transition.
Mgn2a appears to bind to the surface of liposomes made of negatively charged lipids without spontaneously
penetrating the bilayer. Finally, mgn2a and PGLa interact together with liposomes in a synergistic way
that enhances the helix content of one or both of the peptides and allows the peptides to more easily penetrate
the bilayer. PGLa mixed with a small nonperturbing amount of magainin 2 amide is 25-43 times as potent
as PGLa alone a t inducing the release of carboxyfluorescein from liposomes. T h e results suggest that the
mechanism of antimicrobial activity does not involve a channel formed by transmembrane helical peptides.

M a g a i n i n , also known as PGSI (Giovannini et al., 1987;
Terry et al., 1988), is a family of 23-residue peptides that are
secreted from the skin of the African clawed frog. They
protect the frog from wound infection and exhibit a broadspectrum antimicrobial activity in vitro (Zasloff, 1987; Zasloff
et al., 1988). On a molar basis this activity is as potent as
tetracycline against some organisms.
PGLa, another antimicrobial peptide isolated from frog skin,
has an antimicrobial activity that is comparable to that of
magainin 2 (Soravia et al., 1988), but these peptides have little
sequence homology. The sequences of magainin 1 amide
(mgnla), magainin 2 amide (mgn2a), and PGLa are (Giovannini et al., 1987)
mgn 1a: Gly-He-GIy-Lys-Phe-Leu-His-Ser-Ala-Gly-Lys-

magainins might act as detergents or transmembrane helical
channel formers (Zasloff, 1987; Guy & Raghunathan, 1988).
Indeed, measurements using a single channel conductance
apparatus indicate that magainin forms a voltage-dependent
channel in artificial membranes (Cruciani et al., 1988).
Magainin 2 amide causes membrane depolarization in Escherichia coli cells and cytochrome oxidase liposomes (JuretiE
et al., 1989), and magainin 2 amide and PGLa dissipate the
electric potential across energy-transducing membranes, uncoupling respiration from other free-energy-requiring processes
(Westerhoff et al., 1989a,b). The effect of mgnl on the
permeability of liposomes has been investigated by Matsuzaki
et al. (1989), who observe that mgnl induces leakage of calcein
out of negatively charged vesicles and binds to bovine brain
phosphatidylserine according to the Langmuir isotherm with
Phe-Gly-Lys-Ala-Phe-Val-Gly-Glu-Ile-Met-Lys-Ser-NH2
a binding constant of 43.8 X 105/M and that leakage appears
mgn2a: Gly-Ile-Gly-Lys-Phe-Leu-His-Ser-Ala-Lys-Lys- to occur at a binding number of 0.03 per lipid molecule; their
Phe-GI y-Lys-Ala-Phe-Val-GI y-Glu-He- Met-Asn-Ser-NH2
CD measurements indicate that mgnl has an unordered
structure in solution and that it forms a 57% a-helix upon
PGLa: Gly-Met-Ala-Ser-Lys-Ala-Gly-Ala-Ile-Alabinding to PS.
Gly-Lys-Ile-Ala-Lys-Val-Ala-Leu-Lys-Ala-Leu-NH2
CD of peptide in 40% trifluoroethanol (TFE; mixtures of
These peptides are positively charged and can form extremely
water and TFE are used as a membrane mimetic solvent)
amphiphilic helices about 30 A in length. These features are
indicates 24% a-helix (Chen et al., 1988), and N M R of 30
common to polypeptides that bind to and effect the permeamg/mL mgn2a in 25% TFE indicates some a-helix (Marion
bility of lipid bilayers (Sparrow & Goto, 1982; DeGrado et
et al., 1988). Raman measurements show that liposome-bound
al., 1981; Green et al., 1987), and it has been suggested that
mgn2a contains as much as 71% helix (Williams et al.,
1988a,b). These studies also indicate that magainin 2 amide
'This work was funded in part by the Strategic Defense Initiative
Organization Medical Free Electron Laser Program (at USUHS:
Medical Applications of Laser Technology Project Grant GM7160). The
opinions or assertions contained herein are the private ones of the authors
and are not to be construed as official or reflecting the views of the
Department of Defense or the Uniformed Services University of the
Health Sciences.
*Address correspondence to this author.
4 Uniformed Services University of the Health Sciences.
8 Human Genetics Branch, NIH.
11 Department of Mathematical Biology, NIH.

Abbreviations: mgnl, magainin 1; mgn2, magainin 2; mgn2a and
magainin 2a, magainin 2 amide; PGS, peptide beginning with glycine and
ending with serine; PGLa, peptide beginning with glycine and ending with
leucine amide; SDS, sodium dodecyl sulfate; DPPG, L-a-dipalmitoylphosphatidylglycerol; DPPC, dipalmitoylphosphatidylcholine; PS, bovine
brain phosphatidylserine; PC, bovine brain phosphatidylcholine; PE,
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contains 0% helical structure in aqueous solutions.
To ascertain the effect of secondary structure on antimicrobial activity, Chen et al. (1 988) prepared a series of magainin analogues with varying propensities to form helix and
determined the dose-response to these compounds in biological
assays. By substituting residues 9, 13, and 18 with D-alanines,
they prepared a derivative that is unlikely to form a helix. By
substituting glycines 13 and 18 with L-alanine, they increased
the helix-forming tendency of the peptide. The results showed
a positive correlation between antimicrobial activity and
tendency to form helix in TFE. Raman measurements of
secondary structure of these analogues bound to liposomes also
show this correlation (Williams et al., 1 9 8 8 ~ ) .Omission of
glycine 18 in mgn2a does not increase antimicrobial activity,
but does increase hemolytic activity (Cuervo et al., 1988).
In this paper we survey the secondary structure and membrane-perturbing characteristics of mgn2a and PGLa bound
to liposomes under a variety of conditions. We measure the
effect of mgn2a binding on the structure of liposome acyl
chains, and we quantitate the membrane-perturbing kinetics
of mgn2a and PGLa by measuring C F release from CF-loaded
liposomes. Our results show that mgn2a forms an a-helix with
an average length of less than 20 A upon binding to liposomes.
At high concentrations (50 mg/mL) mgn2a spontaneously
solubilizes phosphatidylcholine liposomes at temperatures
above the gel-liquid-crystalline phase transition. Mgn2a appears to bind to the surface of liposomes made of negatively
charged lipids without spontaneously penetrating the bilayer.
Finally, mgn2a and PGLa interact together with liposomes
in a synergistic way that enhances the helix content of one or
both of the peptides and facilitates the peptide's penetration
into the bilayer.
MATERIALS
A N D METHODS
Materials. The purification of magainin 2a and PGLa is
described elsewhere (Zasloff, 1987). Melittin was obtained
from Sigma and further purified by reversed-phase highpressure liquid chromatography on a Waters 8MBC18 10
Radial-Pak C- 18 cartridge. Initial gradient conditions were
70% trifluoroacetic acid and 30% acetonitrile, changing to 40%
trifluoroacetic acid and 60% acetonitrile over 30 min at a flow
rate of 2 mL/min. Synthetic DPPG and DPPC and bovine
brain PC, PE, and PS were obtained from Avanti Polar Lipids
Inc., Pelham AL.
Liposome Preparation. DPPG and DPPC in multilamellar
vesicles (MLVs) were prepared as follows: A solution of lipid
in chloroform was evaporated to dryness in a test tube under
a stream of nitrogen. Then 0.14 M KCl was added to bring
the final lipid concentration to 10-50 mg/mL. This dispersion
was subjected to 10 cycles of vortexing, freezing in dry iceacetone, and thawing to 50 OC. Lipid-bound and unbound
peptide could be rapidly and completely separated by pelleting
the vesicles in a microhematocrit centrifuge.
Small unilamellar vesicles (SUVs) for C F release experiments were prepared as follows: 5 mg/mL phospholipid ( 2 5 3
PC:PE:PS) was evaporated to dryness in a test tube under a
stream of nitrogen and sonicated in a solution of 0.5 M NaCl,
10 mM Pipes, pH 7.0, and 80 mM C F (Kodak) by using a
Heat Systems-Ultrasonics Inc. Model W 185F sonicator with
a cup-horn bath at maximum power for 20 min. These CFloaded vesicles were separated from free C F by elution through
a 2-mL Sephadex G25 column with 0.5 M NaCl and 10 mM
Pipes, pH 7.0. The void volume was collected and diluted to
a lipid concentration of 2.5 mg/mL for storage. These vesicles
were diluted to a concentration of 50 pg/mL lipid in 0.5 M
NaCl and 10 mM Pipes. Aliquots (1 mL) of this dispersion
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were used to measure C F release. Increase in fluorescence
was measured at 520 nm with 470-nm excitation (Weinstein
et al., 1984); 100% fluorescence was determined by the addition of 20 pL of 10% Triton X-100, to a final concentration
of 0.5% Triton.
Magainin 2 amide, PGLa, and melittin solutions were
prepared to 5% w/w in 0.14 M NaCl, and the pH values of
these solutions were adjusted to 7.4 with 0.1 M NaOH. The
formula weights (including neutralizing salts) of mgn2a and
PGLa were taken to be 2701 and 2146, respectively. Peptide-lipid complexes were prepared by mixing 10 pL of peptide
solution with 10 pL of lipid suspension. Samples were pelleted
in melting point capillary tubes with a Damon/IEC microhematocrit centrifuge for 15 min to concentrate the lipidpeptide complex and to exclude supernatant containing unbound peptide. Spectra were collected of the pellets and supernatants of these samples. The pellets were then resuspended
in their respective supernatants and heated at 50 "C; the
magainin-DPPG sample was heated for 30 min, and the
melittin-DPPG sample was heated for 10 min. After 10 min
of heating, the milklike lipid dispersion in the melittin sample
became mostly clear, indicating that large liposomes had been
broken into much smaller particles. Spectra were collected
again. Another 20 pL of DPPG suspension was added to the
magainin and melittin, the pellets were resuspended, the
samples were heated at 50 "C for 30 min, and spectra were
collected again.
Raman Spectroscopy. Raman instrumentation is described
elsewhere (Williams, 1986). The laser was operated at 514.5
nm with typically 200 mW of light power focused at the
sample to a beam with a diameter of about 0.5 mm for precipitates of lipid and peptide, and a diameter of about 0.1 mm
for solutions and supernatants. The thermostated sample
holder was held at 14 "C.
Raman spectra of peptides were analyzed for secondary
structure information according to the method of Williams
(1983, 1986). Briefly, fractions of helix, &strand, reverse turn,
and unfolded structure are estimated from the Raman spectrum of the peptide by fitting the amide I spectrum with a
linear combination of amide I spectra of proteins whose
structures are known by X-ray diffraction. The secondary
structure is then calculated as a sum of fractions of the reference proteins. The procedure used here differs from the one
described (Williams, 1986) in that the spectrum of lysozyme
in 4 M guanidine hydrochloride (Gdn-HC1) was added to the
set of reference spectra. This amide I spectrum is identical
with the spectra of several other proteins in unfolding concentrations of Gdn-HC1 and is taken here to represent the
spectrum of a protein or peptide that is unfolded.
Subtraction of the spectrum of water from spectra of peptide-lipid mixtures cannot be performed by the method described earlier (Williams, 1986) because of the strong phospholipid ester C=O stretching band between 1700 and 1780
cm-I. The correct amount of water spectrum to be subtracted
was determined as follows: After collection of Raman spectra
of the pelleted vesicles, the pellet was evaporated to dryness
under a stream of nitrogen and the Raman spectrum of the
dry pellet collected. (This drying treatment does not completely dehydrate liposome samples.) Water subtraction was
adjusted to bring the water-subtracted spectrum into congruence with the dehydrated sample spectrum. These spectra
were generally identical.
We define here a new expression for a lipid order parameter
(LOP) to quantitate the effect of peptides on the structure of
phospholipids
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I1 128,GP sample - I1 125,LCP reference
LOP =

I1095.GP sample

11095,LCP reference

I1 128,GP reference - I1 I25,LCP reference
I1095,GP reference

z1095,LCP reference

where IIlzsis the Raman intensity at 1128 cm-I and the G P
reference is the spectrum of gel-phase (GP) multilamellar lipid
vesicles (MLVs) prepared by freezing and thawing in normal
saline. The spectrum is measured at a temperature (14 OC
in this case) well below both the main and premelting gel to
liquid-crystalline phase (LCP) transitions. The LCP reference
is the spectrum of the same vesicles measured at a temperature
(50 OC for DPPG) well above the main G P to LCP transition.
The intensity at 1095 cm-I is an iso-Raman point for the
melting transition (Gaber et al., 1978) and is used to normalize
each spectrum.
This parameter (LOP) indicates the intensity of the 1128cm-l band (which is due to coupled vibrations from adjacent
trans bonds) relative to its intensity in nearly all trans structures (solid), where LOP = 1, and all melted structures, where
LOP = 0. This band is generally accepted to be the most
reliable indicator of this structure change. We cannot presently
explain the changes observed in the 1064-cm-' band. The
1 128-cm-l band does not indicate the number of gauche and
trans bonds, since the intensity of these bands is probably not
a linear function of conformation. Nor does it indicate to what
extent the peptide is or is not inserted into the acyl-chain region
of the bilayer. It does, however, give a relative indication of
how peptide binding disrupts (or orders) the lipid acyl-chain
structure.
Analysis of CF Release. C F fluorescence data were converted to percent C F remaining in vesicles by the expression
%CF,,, = ( 1 - F/FT)/Qv,where F is fluorescence measured
at any time, FT is total C F fluorescence after disruption of
vesicles with Triton, and Qvis a correction for the residual
fluorescence of dye in the vesicles (Weinstein et al., 1984).
To quantitate differences between the membrane-perturbing
abilities of PGLa and a mixture of PGLa and mgn2a, a
double-exponential fit was applied to the C F release data by
using the SAAM (Simulation, Analysis And Modeling) program
(Berman & Weiss, 1978). C F remaining in liposomes was
expressed as CFrem(%)
= Aeklr+ BekZt,where A and B are
proportionality coefficients with A B = 100, t is time, and
k l and k2 are pseudo-first-order rate constants where kl =
K,[peptide] C and k2 = KJpeptide] + C. Constants for
liposome permeability, K1 and K2, were estimated as the slope
of the linear regression line through k l and k2 plotted as a
function of peptide concentration (Figure 5). For example,
for PGLa alone, K, = Ak,/A[PGLa] = 0.16 (s.M)-'. There
are a number of ways to analyze this type of kinetic data
(Bentz et al., 1988; Bentz & Nir, 1981). We have chosen the
presentation described here to emphasize the differences between the effects of each isolated peptide and a mixture of
mgn2a and PGLa.

+

+

RESULTSAND DISCUSSION
a-Helical Peptides. Figure 1 shows the Raman amide I
spectra of magainin 2 amide (mgn2a) compared with spectra
of other peptides and proteins with known structures. One
of these structures is that of melittin, a 26-residue amphipathic
peptide that is 96% helix in the crystal (Terwilliger et al.,
1982). We compare spectra of mgn2a to those of melittin
because melittin is similar in some ways to mgn2a in size,
charge, and amphipathicity and because much is already

Williams et a].
Table I: Secondary Structure Content" (Percent) in Magainin 2a
and PGLa from the Raman Amide I SDectrum
structure type
peptide
helix &strand turn unfolded
0
3
1
96
mgn2a, 0.14 M NaCI, pH 7.4
0
0
0
100
mgn2a, water, pH 7.1
0
0
101
mgn2a, dilute HCI, pH 3.2
0
0
0
99
0
mgn2a, 5.8 M GdmHCI
45
18
19
6
mgn2a precipitate in saline
PGLa, 0.14 M NaCI, pH 7.4
PGLa, water, pH 7.0
PGLa, dilute HCI, pH 3.2
PGLa, 5.5 M GdneHCI, pH 7.3
PGLa ppt in 0.14 M NaCI, pH 7.4

6

59

3

21
63
6
19
69

mgn2a:DPPC 1:l (1:3.7), pH 8.5,
suptb
mgn2a:DPPC 1:3 (1:ll by mole),
pH 3.6
mgn2a:DPPC 1:16 (1:59), 50 OC

47

19

20

2

46

19

22

0

35

31

23

0

mgn2a:PGLa:DPPC l : l : l , pH 7.4
mgn2a:PGLa:DPPC 1 :1 :2, pH 7.4
mgn2a:PGLa:DPPC l : l : l , pH 3.6

30
37
14

15
26
8

12
12
5

34
15
70

mgn2a:DPPG 1 : 1 , pH 7.4
PGLa:DPPG 1 : 1 , pH 7.0
mgn2a:DPPG 1 : 1 , pH 3.6
PGLa:DPPG I:], pH 3.6
mgn2a:PGLa:DPPG 1:1:2, pH 3.6
mgn2a:PGLa:DPPG l : l : l , pH 3.5

58
3
45
27
53
47

14
67
19
45
18
20

20
23
22
25
22
23

0
0
0
0
0
0

mgn2a:PGLa 1:1, water, pH 7.1
mgn2a:PGLa 1:1, dilute HCI,
pH 3.2
mgn2a + PGLa, sum of data,
pH 3.2

0
0

2
4

1
1

97
94

0

0

0

100

mgn2a:DMPC 1:4, pH 7.3, supt
mgn2a:DMPC 1:4, pH 7.3, pellet
PGLa:DMPC 1 : 1 , water, pH 7.0

59
46
42

12
20
15

18
23
13

0
0

19

mgn2a:SDS 1:1, post 50 "C
mgn2a in 20% TFE

47
0

20
30

23
10

54

melittin crystalsC
melittin, 0.14 M NaCI, pH 7.4
me1ittin:DPPG
ribonuclease S-peptide:DPPG 1 :1

84
82
73
0

4
5
9
7

7
7
10
2

0
0
0
91

1
0
0

8
21
2
6
24

90
71
0

0

0

f4
f 2
standard deviations"
f5
"The sum of structure contents was 100 f 2%. Undefined structure
content, the remainder from loo%, is not shown. Standard deviations
represent differences between Raman and X-ray diffraction measurements for the reference proteins. b"supt"indicates that liposomes were
dissolved by peptide and that the spectrum was taken of the clear supernatant above pelleted material. Melittin, having a 96% helical
crystal structure, was excluded from the reference set for this calculation. Melittin was not excluded from the reference set for estimates of
its structure in DPPG and 0.14 M NaCI.

known about the structure of melittin and its interaction with
lipid bilayers (Brown et al., 1982; Bernard et al., 1982;
Georghiou et al., 1982; DeGrado et al., 1982; Levin et al.,
1982). In addition, there is an error in the Raman estimate
of helix content in melittin that may also exist in the estimate
for helical mgn2a samples; the Raman estimate of helix
content in melittin crystals (Table I) is 8495, which is 12%
(three residues) below the X-ray diffraction structure. This
difference may be due to end effects, since the ends of helical
segments have an amide I spectrum different from that of
residues in the middle of a helical segment (Williams &
Dunker, 1981). We suspect that helical residues that are on
the very ends of a peptide (as they are in melittin) will have
yet a different amide I spectrum. Our estimate of helix content
for mgn2a in DPPG here is 58% (Table I). If we assume that

Raman Spectroscopy of Frog Peptides
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Frequency shift, cm-I

Amide 1 Raman spectrum of magainin 2 amide bound to
DPPG liposomes, compared with reference spectra of peptides and
proteins with known structures. Mgn2a:DPPG 1:l (ratios are by
weight) in saline, pH 7.4 (heavy dotted line); melittin crystals, >96%
helix (light dotted line); me1ittin:DPPG 1:1 in saline, pH 7.4 (solid
line); melittin in saline, pH 7.4 (line with one dot); hemerythrin, 80%
helix in a four-helix bundle (line with one dash); concanavalin A
crystals, 65% @-sheet-2% helix (dashed line); erabutoxin, 62%.psheet-0% helix (line with three dots); unfolded ribonuclease S-peptide
(thin line with two dots); lysozyme unfolded in 4 M guanidine hydrochloride (line with two dashes).
FIGURE 1 :

this estimate is also 12% low, we can set an upper limit of 70%
helix for the average helix content in this sample of mgn2a.
This corresponds to 16 residues, 24 8, in an a-helix, which is
not long enough to span a lipid bilayer.
The spectrum of a helical peptide bound to lipid vesicles or
in solutions may be different from the spectrum of the same
peptide, with the same structure, in a crystal. To investigate
this possibility in the context of helical peptides that may form
bundles that span lipid bilayers, we collected Raman spectra
of melittin bound to lipid vesicles and in solution. As can be
seen in Figure 1, the differences between the spectra of crystal
and lipid-bound structures are relatively small.
We show in Figure 1 the spectra of proteins and peptides
that illustrate the validity of using a database of Raman
spectra of relatively large proteins for an analysis of the spectra
of a 23-residue peptide. Erabutoxin has 62 residues, 3 disulfides, and is 50% p-sheet-0% helix (Low et al., 1976).
Concanavalin A has 237 residues, contains no cysteines, and
is 51% p-sheet-2% helix (Reeke et al., 1975). The secondary
structure contents and the amide I spectra of these proteins
are nearly identical. The spectrum of hemerythrin, a 113residue 80% helical protein, is similar to the spectra of melittin,
differing only in the way expected for two helical proteins that
differ in helix content. The amide I spectrum of the 24-residue
ribonuclease S-peptide in its unfolded structure (Kim et ai.,
1982) is nearly identical with the spectrum of lysozyme in
guanidine hydrochloride, indicating that it is valid to use this
spectrum of lysozyme as a reference for unfolded structure.
There is no indication that secondary structure in a 20-residue
peptide will have an amide I spectrum that is different from
the same secondary structure in a large protein.
Interaction with Liposomes. The interactions of mgn2a with
negatively charged DPPG and with zwitterionic DPPC and
DMPC vesicles are different. When mgn2a was added to
dispersions of DPPG MLVs, the vesicles rapidly flocculated.
The flocculated appearance of these samples remained unchanged when they were heated to a temperature above the
gel to liquid-crystalline phase transition. These aggregated
vesicle-peptide complexes were easily separated from free
mgn2a that might be left in the solution. We observed a
marked change in the light scattering from lipid dispersions
upon addition of peptides. Since we have no quantitative
light-scattering measurements from these samples, some of
them only 5 pL, we describe this change qualitatively here by
comparing the appearance of the dispersion to milk, where light

Frequency shift, cm-'

FIGURE 2: Amide I Raman spectrum of magainin 2 amide bound to
liposomes and in solution. The spectra of melittin crystals (dotted
line) and of unfolded ribonuclease S-peptide (thin line with two dots)
are shown in both panels as references. (A) Mgn2a:DPPG 1:1 (ratios
are by weight) in saline, pH 7.4 (solid line); mgn2a:DMPC 1:4 in
water, pH 7.3 (line with one dot); mgn2a 200 mg/mL in 5.8 M
Gdn-HCI, pH 7 (line with one dash); mgn2a precipitated at 14 OC
in saline, pH 7.4 (dashed line); mgn2a in saline solution at 22 OC,
pH 7.4 (line with three dots). (B) Mgn2a:DPPC 1:3 in saline, pH
3.6, after 50 OC, 15 min, clear dispersion (line with three dots);
mgn2a:DPPC 1:1 pH 8.5, after 50 "C, 30 s, clear dispersion (line with
one dot); mgn2a:SDS 1:1.5 after 50 OC, 30 s, clear solution (solid
line); mgn2a in 20% TFE in water (line with one dash); concanavalin
A crystals, a 55% P-sheet-2% helix reference protein (dashed line).

scattering is very high, before addition of peptide, and as
becoming clear (as water) after addition. When mgn2a was
added to the milky dispersions of DPPC and DMPC, no
change was observed. However, when these samples were
heated to a temperature above the gel to liquid-crystalline
phase transition, they immediately became clear, indicating
that the liposomes were solubilized into much smaller particles.
The interactions of melittin with both DPPG and DPPC were
more similar; the milky vesicle dispersion became nearly clear
in both cases, even to some extent at temperatures below the
gel to liquid-crystalline phase transitions. They were not as
clear as those obtained from mgn2a in DPPC and DMPC.
The structure of mgn2a changes upon binding to lipid
vesicles from a mostly unfolded structure in aqueous solution
to a helical structure in the peptide-lipid complex (Figure 2;
Table I). The amide I spectra of mgn2a in aqueous solutions
or in Gdn-HC1 are to some extent different from our reference
spectrum for unfolded peptide structure (Figure 2A). This
may indicate that, while being mostly unfolded, the peptide
has some preferred turn structure in solution, and there may
be some artifact from the subtraction of the Gdn.HC1 spectrum. The structure of mgn2a appears to be similar bound
to DPPG and DMPC (Figure 2A; Table I), but helix content
is lower in DPPC by more than 10% (two residues). The
mgn2a structures in the form precipitated from aqueous solution in the cold (Figure 2A) and in DPPC (Figure 2B) are
similar.
The ratio of lipid to peptide may affect peptide structure,
especially in mixtures of mgn2a and DPPC where vesicles are
solubilized by the peptide and free peptide cannot be separated
from the peptide-lipid complex. To test this possibility, samples of Mgn2a-DPPC were measured at mole ratios of 1:3.7,
1:11, and 159. At the 1 5 9 ratio the dispersion retained much
of its turbid appearance after the addition of peptide and
incubation at 50 "C. The mgn2a structure did not change

Williams et al.
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1050

Table 11: Lipid Order Parameters from the C-C Stretching Raman
Spectra of Peptide-Lipid Complexes
complex
pre 50 O C ” post 50 OC
mgn2a:DPPG 1:1, pH 7.4
0.73
0.59
0.65
0.23
me1ittin:DPPG 1:1
ribonuclease S-peptide:DPPG 1 : 1
0.46
0.36
mgn2a:DPPC 1:l (1:3.7), pH 8.5, suptb
1.00
0.83
0.90
0.71
me1ittin:DPPC 1:l
‘Samples were measured before and after the sample was incubated
at 50 OC for 10-30 min. b”supt”indicates that liposomes were dissolved by peptide and that the spectrum was taken of the clear supernatant above pelleted material.
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Frequency shift, cm-’

FIGURE 3: Raman spectra of pellets of lipid LUVs in PBS (unless
otherwise indicated) with and without bound peptide, showing the
lipid acyl-chain C-C stretching region, and in particular the band
at 1 1 28 cm-I, that indicates (nonlinearly) the extent of trans-gauche
isomerization. The top frame shows spectra of DPPG well below the
gel to liquid-crystalline phase transition at 14 OC (thin solid line) and
of DPPG just above this transition, at 45 OC (thin dashed line);
mgn2a:DPPG 1:l at 14 OC, pH 7.4 (the band at 1032 is from the
mgn2a phenylalanines) (line with one dot); mgn2a:DPPG 1:l at 14
OC, pH 7.4, after 30 min at 50 OC (dotted line); me1ittin:DPPG 1:l
at 14 “C, pH 7.4 (line with one dash); melittin:DPPG 1:l at 14 OC,
pH 7.4, after 10 min at 50 OC (line with two dashes); ribonuclease
S-peptide:DPPG 1:l at 14 OC, pH 7.4, after 30 min at 50 OC (this
spectrum is the same before the 50 O C treatment) showing that
ribonuclease S-peptide in an unfolded structure disrupts the lipid
acyl-chain structure more than mgn2a (thin line with three dots).
(Bottom frame) DPPC at 14 OC (thin solid line); DPPC at 45 OC
(thin dashed line); mgn2a:DPPC 1:l at 14 OC, pH 3.7, showing that
mgn2a does not copellet with DPPC liposomes (line with one dot);
mgn2a:DPPC 1:l at 14 OC, pH 8.5, after 10 min at 50 OC (liposomes
are dissolved by this treatment; this spectrum was taken of a clear
solution) (dotted line); me1ittin:DPPC 1:l at 14 OC, pH 5.3 (liposomes
are dissolved by this treatment, but not to a clear solution as with
mgn2a; this spectrum was taken of a translucent dispersion) (line with
one dash); me1ittin:DPPC 1:l at 14 OC, pH 5.3, after 10 min at 50
OC showing that heating this mixture to above the gel to liquidcrystalline phase transition does not induce further changes in the
lipid structure (line with two dashes). Ratios are by weight.

significantly as the amount of DPPC was increased (Figure
2B; Table I). Spectra collected a t 50 OC were not significantly
different from spectra collected a t 14 OC,as was the case with
spectra collected from samples a t pH 7-9 and a t p H 3-4.
Membrane Mimetic Solvents. Spectra of mgn2a in membrane mimetic environments, mixed with S D S and in 20%
trifluoroethanol (TFE), are significantly different from spectra
of the peptide mixed with lipid vesicles (Figure 2B). These
results indicate that S D S and TFE may not be good model
solvents for magainins in a membrane environment. Other
peptides have shown “distinctly different conformations in
membranes and in organic solvents” (Wallace, 1983). Raman
measurements of magainin 2 amide at 50 mg/mL in 20% T F E
(Table 11) appear to be in conflict with the N M R results
(Marion et al., 1988) that indicate mgn2a is helical in dilute
TFE solutions. However, the N M R measurements were made
of solutions that contained higher concentrations of TFE. Our
results from magainins in T F E will be reported more fully
elsewhere.
Lipid Acyl-Chain Disorder. The extent of lipid acyl-chain
disorder induced by peptide binding to DPPG and DPPC was
measured from the Raman spectrum in the C-C stretching
region (Figure 3) and quantitated in terms of our LOP (Table

Frequency shift, cm-’

Amide I Raman spectra of PGLa and mixtures of PGLa
and mgn2a bound to liposomes and in solution. The spectra of melittin
crystals (dotted line) and unfolded ribonuclease S peptide (line with
two dots) are shown in both frames as references. (A) PGLa precipitate in 0.14 M NaC1, pH 7.4 (solid line);PGLa:DPPG 1:l in dilute
HCI, pH 3.6 (line with one dot); PGLa in water pH 7.0 (line with
one dash); PGLa in water, pH 3.2 (line with three dots); PGLa in
0.14 M NaCI, pH 7.4 (dashed line); PGLa:DMPC 1:1, pH 7.0 (line
with two dashes). (B) Mgn2a:PGLa:DPPG 1:1:2,pellet of vesicles
(solid line); arithmetic sum of the spectra of mgn2a:DPPG 1:l and
PGLa:DPPG 1:l (line with three dots); mgn2a:PGLa 1:l in water,
pH 7.1 (line dot); arithmetic sum of spectra of mgn2a in saline, pH
7.4, and PGLa in water, pH 7.0 (line all dash).
FIGURE4:

11). The acyl chains of DPPG appear to be slightly more
disordered (contain more gauche conformations) after incubation with mgn2a a t 50 “C, but the spectrum between 1000
and 1030 cm-I (not shown) shows an increase in the intensity
of the 1003-cm-’ mgn2a phenylalanine band that is proportional to the decrease in the intensity of the DPPG bands upon
heating. This indicates that this increase in acyl-chain disorder
is probably due to an increase in the amount of mgn2a bound
to the DPPG vesicles and not to a change in structure. Melittin
is more disruptive than mgn2a and completely disorders the
acyl chains after incubation a t 50 OC, possibly by forming
peptide-lipid micelles.
DPPC appears to be much less disordered by mgn2a or
melittin than DPPG, even in samples of Mgn2a-DPPC complex that have turned clear after heating a t 50 OC. These
results, combined with our qualitative observation that mgn2a
solubilizes DPPC liposomes and greatly reduces their light
scattering, may indicate that the Mgn2a-DPPC complex
formed after heating is a disk-shaped micelle in which the lipids
can form a planar bilayer within a ring of peptide molecules.
A similar annular protein-bilayer disk model has been proposed
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FIGURE 5 : Intensity of CF fluorescence after addition of antimicrobial
peptide to CF loaded liposomes. Numbers to the right, next to each
curve, indicate final concentrations of peptide in micrograms per
milliliter, where IO pg/mL PGLa is 4.66 pM and 10 wg/mL mgn2a
is 3.7 pM. (Top) Magainin 2a was added at time 0. (Middle) PGLa
was added at time 0. (Inset) Pseudo-first-order rate constants (see
Materials and Methods) plotted as a function of PGLa concentration.
Solid symbols represent k , , and open symbols represent k2. PGLa
k , (open triangle); PGLa k2 (solid box); mixture (3.7 gM mgn2a plus
indicated amount of PGLa) k , (solid circle); mixture k2 (open circle).
(Bottom) Magainin 2a was added to liposomes to a final concentration
of 3.7 pM 30 s prior to the addition of PGLa. Time 0 indicates the
addition time of PGLa. The mixture at a ratio of 1:20 PGLa to mgn2a
is as active as a 23-fold higher concentration of PGLa alone.

for apolipoprotein A-I (Brouillette et al., 1982).
We added ribonuclease S-peptide to DPPG liposomes to
provide a comparison of our results with mgn2a with the
liposome binding behavior of another positively charged peptide
of about the same size as mgn2a, but with much lower helix
hydrophobic moment and fewer hydrophobic residues. Ribonuclease S-peptide copellets with DPPG liposomes in an
unfolded or random structure (Table I) and disrupts the lipid
acyl chains of gel-phase DPPG more than either mgn2a or
melittin. Because the S-peptide is not helical in this membrane-bound state, we suspect that this interaction is mainly
electrostatic and that penetration of the hydrophobic acyl-chain
region of the bilayer is minimal. This suggests that peptide
structures other than helix can significantly disrupt lipid bilayers, changing their permeability and surface area.
PGLa Structure. PGLa is less soluble in aqueous solutions
than is mgn2a, reversibly forming a precipitate in saline at pH
7.4 and low temperatures that contains @-sheetand reverse
turn structure. It forms a mostly unfolded structure in water
at pH 3.2, in saline at pH 7.4, and at ambient temperatures
(Figure 4A; Table I). PGLa forms a /3-sheet structure in water
at neutral pH, probably in an aggregated form, although these
solutions are clear. Upon binding to DPPG, PGLa shows an
amide I band similar to that observed for the precipitated form.
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Upon binding to DMPC, the structure of PGLa becomes a
42 f 5% helical.
Synergistic Interaction of Mgn2a and PGLu. PGLa is only
27 f 5% helix when bound to DPPG, but an equimolar
mixture of PGLa and mgn2a appears to contain significantly
more helix when bound to DPPG than the average of the
separate peptides (Table I; Figure 4B). Equimolar mixtures
of PGLa and mgn2a in water do not interact in this way to
form secondary structure.
One of the most striking features of these peptides is that
they appear to act synergistically. To measure the membrane-perturbing activity of mgn2a and PGLa at physiologically active concentrations, we measured the release of 6carboxyfluorescein (CF) from liposomes as a function of
peptide concentration and calculated constants related to
membrane-perturbing activity (Figure 5 ) . Mgn2a does not
release C F at 10 pg/mL (3.7 pM). This is consistent with
the low hemolytic activity of mgn2a. PGLa does release C F
at relatively low concentrations. However, in the presence of
10 pg/mL mgn2a, PGLa is dramatically more active. For
PGLa alone, K , and K2 = 0.16 and 0.007 (s.M)-', respectively.
For PGLa with 3.7 pM mgn2a, K , and K2 = 4.0 and 0.3
(s.M)-', respectively. The change in K 1 and K2caused by the
presence of an amount of mgn2a that by itself does not cause
permeability is 25- and 43-fold, respectively. These results
suggest that the interaction of these two antimicrobial peptides
at the membrane surface produces a structure change in one
or both of the peptides that potentiates the antibiotic activity.
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